Core Viewpoint - Shenzhen's Industrial and Information Technology Bureau has issued the "Shenzhen 'Artificial Intelligence +' Advanced Manufacturing Action Plan (2026-2027)", focusing on accelerating innovation and transformation in drug research and development, cell and gene therapy, and precision medical services [1] Group 1: Action Plan Objectives - The plan aims to promote technological innovation in key areas such as drug target discovery and validation, drug design, high-throughput drug screening, DNA-encoded compound library screening, computer-aided drug design, virtual screening, and gene locus screening related to drug therapy [1] - It supports the establishment of major platforms for AI-driven drug research and development, enhancing the integration of technological resources [1] Group 2: AI and Biotechnology Integration - The initiative emphasizes the deep integration of artificial intelligence and biotechnology (AI+BT) to accelerate advancements in the sector [1]
深圳：加快药物研发、细胞与基因治疗、精准医疗服务的研发创新与成果转化
Jin Rong Jie·2026-02-12 11:14